...
首页> 外文期刊>Urology >Computer-aided (HistoScanning) biopsies versus conventional transrectal ultrasound-guided prostate biopsies: Do targeted biopsy schemes improve the cancer detection rate?
【24h】

Computer-aided (HistoScanning) biopsies versus conventional transrectal ultrasound-guided prostate biopsies: Do targeted biopsy schemes improve the cancer detection rate?

机译:计算机辅助(组织扫描)活检与常规经直肠超声引导的前列腺活检:靶向活检方案是否可以提高癌症检出率?

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To define potential improvement in prostate cancer detection by application of a computer-aided, targeted, biopsy regimen using HistoScanning. Materials and Methods: We analyzed 80 patients who underwent systematic transrectal, targeted transrectal, and targeted perineal biopsies. Each patient was diagnosed preoperatively by HistoScanning, defining a maximum of 3 suspicious areas. These areas were biopsied, both transrectally and via the perineum, with a maximum of 3 cores per location. Results: We detected prostatitis in 30 patients (37.5%), premalignant lesions in 10 (12.5%), and prostate cancer in 28 (35%). The transrectal technique was used to detect 78.6% of all cancers using 14 cores by systematic biopsy. With a maximum of 9 targeted cores, 82.1% of all cancers were detected with the targeted perineal approach and 53.6% were detected with the targeted transrectal approach. Although our data did not show significant difference in the performance of targeted transperineal compared with systematic transrectal biopsies, the detection rate of targeted transrectal biopsies was significantly lower. Conclusion: The presented targeted biopsy scheme achieved an overall detection rate of 85% of prostate-specific antigen-relevant pathologic lesions within the prostate. Thus, the presented procedure shows an improved detection rate compared with standard systematic prostate biopsies, and the number of cores required is reduced. Furthermore, the perineal HistoScanning-aided approach seems to be superior to the transrectal approach with respect to the prostate cancer detection rate. The presented procedure might be a step toward reliable ultrasound-based tissue characterization and toward fulfilling the requirements of novel therapeutic strategies. ? 2013 Elsevier Inc.
机译:目的:通过应用组织免疫,有针对性的活检方案,利用HistoScanning定义前列腺癌检测的潜在改善。材料和方法:我们分析了80例行系统性经直肠,靶向经直肠和靶向会阴活检的患者。术前通过HistoScanning诊断每位患者,最多可定义3个可疑区域。对这些区域进行经直肠和会阴活检,每个位置最多3个芯子。结果:我们检出了30例患者的前列腺炎(37.5%),恶性病变10例(12.5%),前列腺癌28例(35%)。经直肠穿刺技术通过系统活检,使用14根核芯检测出所有癌症的78.6%。在最多9个靶向核心的情况下,使用会阴靶向治疗可检测到82.1%的癌症,而经直肠靶向治疗可检测到53.6%的癌症。尽管我们的数据未显示与系统经直肠穿刺活检相比靶向经会阴穿刺活检的性能有显着差异,但靶向经直肠穿刺活检的检出率明显较低。结论:提出的靶向活检方案实现了前列腺内与前列腺特异性抗原相关的病理病变的总检出率为85%。因此,与标准的系统前列腺活检相比,本方法显示出更高的检测率,所需的核心数量也减少了。此外,就前列腺癌的检出率而言,会阴组织扫描辅助方法似乎优于经直肠方法。提出的程序可能是迈向可靠的基于超声的组织表征和满足新型治疗策略要求的一步。 ? 2013爱思唯尔公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号